Cite
APA Citation
O'Sullivan, J., Gillessen, S., Heidenreich, A., Heinrich, D., Gratt, J., Lévy, J., Miller, K., Nilsson, S., Saad, F., Tucci, M., Wirth, M., & Carles, J. (n.d.). 2561 Effects of concomitant use of abiraterone and/or enzalutamide with radium-223 on safety and overall survival in metastatic castration-resistant prostate cancer (mCRPC) patients treated in an international early access program (EAP). European journal of cancer, 51, S497–S498. http://access.bl.uk/ark:/81055/vdc_100030628240.0x000062